|
[1]
|
Haland, T.F., Hasselberg, N.E., Almaas, V.M., Dejgaard, L.A., Saberniak, J., Leren, I.S., et al. (2017) The Systolic Paradox in Hypertrophic Cardiomyopathy. Open Heart, 4, e000571. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Sakellaropoulos, S., Svab, S., Mohammed, M., Lekaditi, D. and Mitsis, A. (2021) The Role of Mitral Valve in Hypertrophic Obstructive Cardiomyopathy: An Updated Review. Current Problems in Cardiology, 46, Article 100641. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Ommen, S.R., Mital, S., Burke, M.A., et al. (2020) 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 142, e558-e631.
|
|
[4]
|
Haland, T.F. and Edvardsen, T. (2019) The Role of Echocardiography in Management of Hypertrophic Cardiomyopathy. Journal of Echocardiography, 18, 77-85. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Rakowski, H., Hoss, S. and Williams, L.K. (2019) Echocardiography in the Diagnosis and Management of Hypertrophic Cardiomyopathy. Cardiology Clinics, 37, 11-26. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Inciardi, R.M., Galderisi, M., Nistri, S., Santoro, C., Cicoira, M. and Rossi, A. (2018) Echocardiographic Advances in Hypertrophic Cardiomyopathy: Three-Dimensional and Strain Imaging Echocardiography. Echocardiography, 35, 716-726. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Mandeş, L., Roşca, M., Ciupercă, D. and Popescu, B.A. (2020) The Role of Echocardiography for Diagnosis and Prognostic Stratification in Hypertrophic Cardiomyopathy. Journal of Echocardiography, 18, 137-148. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Erden, M., van Velzen, H.G., Menting, M.E., van den Bosch, A.E., Ren, B., Michels, M., et al. (2018) Three-Dimensional Echocardiography for the Assessment of Left Ventricular Geometry and Papillary Muscle Morphology in Hypertrophic Cardiomyopathy. Journal of Ultrasound, 21, 17-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Cardim, N., Galderisi, M., Edvardsen, T., Plein, S., Popescu, B.A., D’Andrea, A., et al. (2015) Role of Multimodality Cardiac Imaging in the Management of Patients with Hypertrophic Cardiomyopathy: An Expert Consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. European Heart Journal—Cardiovascular Imaging, 16, 280-280. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
赵含章, 李颖, 冀威, 等. 实时三维超声心动图结合二维斑点追踪技术评价运动负荷前后对肥厚型非梗阻性心肌病患者右心室功能的影响[J]. 医学影像学杂志, 2022, 32(1): 66-71.
|
|
[11]
|
宋源凯, 林红, 简宇鹏, 等. 三维测量指导左室流出道疏通手术治疗肥厚型梗阻性心肌病及长期疗效[J]. 中国胸心血管外科临床杂志, 2023, 30(11): 1580-1585.
|
|
[12]
|
Finocchiaro, G., Dhutia, H., D’Silva, A., Malhotra, A., Sheikh, N., Narain, R., et al. (2018) Role of Doppler Diastolic Parameters in Differentiating Physiological Left Ventricular Hypertrophy from Hypertrophic Cardiomyopathy. Journal of the American Society of Echocardiography, 31, 606-613.e1. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Ziółkowska, L., Petryka, J., Boruc, A. and Kawalec, W. (2017) Comparison of Echocardiography with Tissue Doppler Imaging and Magnetic Resonance Imaging with Delayed Enhancement in the Assessment of Children with Hypertrophic Cardiomyopathy. Archives of Medical Science, 2, 328-336. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Ito, T. and Suwa, M. (2020) Echocardiographic Tissue Imaging Evaluation of Myocardial Characteristics and Function in Cardiomyopathies. Heart Failure Reviews, 26, 813-828. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Kalra, A., Harris, K.M., Maron, B.A., Maron, M.S., Garberich, R.F., Haas, T.S., et al. (2016) Relation of Doppler Tissue Imaging Parameters with Heart Failure Progression in Hypertrophic Cardiomyopathy. The American Journal of Cardiology, 117, 1808-1814. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Geske, J.B., Ommen, S.R. and Gersh, B.J. (2018) Hypertrophic Cardiomyopathy. JACC: Heart Failure, 6, 364-375. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
常旭东, 薛莉. 超声心动图评估肥厚型心肌病左室功能的临床研究进展[J]. 医疗卫生装备, 2022, 43(3): 90-95.
|
|
[18]
|
Baudry, G., Mansencal, N., Reynaud, A., Richard, P., Dubourg, O., Komajda, M., et al. (2019) Global and Regional Echocardiographic Strain to Assess the Early Phase of Hypertrophic Cardiomyopathy Due to Sarcomeric Mutations. European Heart Journal—Cardiovascular Imaging, 21, 291-298. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Fujimoto, K., Inoue, K., Saito, M., Higashi, H., Kono, T., Uetani, T., et al. (2018) Incremental Value of Left Atrial Active Function Measured by Speckle Tracking Echocardiography in Patients with Hypertrophic Cardiomyopathy. Echocardiography, 35, 1138-1148. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Wu, X., Li, Y., Zhang, M., Zhu, W., Cai, Q., Jiang, W., et al. (2019) Impaired Left Ventricular Mechanics and Functional Reserve Are Associated with Reduced Exercise Capacity in Patients with Hypertrophic Cardiomyopathy. Echocardiography, 36, 266-275. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Parato, V.M., Antoncecchi, V., Sozzi, F., Marazia, S., Zito, A., Maiello, M., et al. (2015) Echocardiographic Diagnosis of the Different Phenotypes of Hypertrophic Cardiomyopathy. Cardiovascular Ultrasound, 14, Article No. 30. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Zegkos, T., Parcharidou, D., Ntelios, D., Efthimiadis, G. and Karvounis, H. (2018) The Prognostic Implications of Two-Dimensional Speckle Tracking Echocardiography in Hypertrophic Cardiomyopathy. Cardiology in Review, 26, 130-136. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Saito, M., Okayama, H., Yoshii, T., Higashi, H., Morioka, H., Hiasa, G., et al. (2012) Clinical Significance of Global Two-Dimensional Strain as a Surrogate Parameter of Myocardial Fibrosis and Cardiac Events in Patients with Hypertrophic Cardiomyopathy. European Heart Journal—Cardiovascular Imaging, 13, 617-623. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Reant, P., Mirabel, M., Lloyd, G., Peyrou, J., Lopez Ayala, J., Dickie, S., et al. (2016) Global Longitudinal Strain Is Associated with Heart Failure Outcomes in Hypertrophic Cardiomyopathy. Heart, 102, 741-747. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Földeák, D., Kormányos, Á., Domsik, P., Kalapos, A., Piros, G.Á., Ambrus, N., et al. (2017) Left Atrial Dysfunction in Light-Chain Cardiac Amyloidosis and Hypertrophic Cardiomyopathy—A Comparative Three-Dimensional Speckle-Tracking Echocardiographic Analysis from the Magyar-Path Study. Revista Portuguesa de Cardiologia, 36, 905-913. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Kleijn, S.A., Brouwer, W.P., Aly, M.F.A., Russel, I.K., de Roest, G.J., Beek, A.M., et al. (2012) Comparison between Three-Dimensional Speckle-Tracking Echocardiography and Cardiac Magnetic Resonance Imaging for Quantification of Left Ventricular Volumes and Function. European Heart Journal—Cardiovascular Imaging, 13, 834-839. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Badran, H.M., Faheem, N., Soliman, M., Hamdy, M. and Yacoub, M. (2019) Comparison of Vector Velocity Imaging and Three-Dimensional Speckle Tracking Echocardiography for Assessment of Left Ventricular Longitudinal Strain in Hypertrophic Cardiomyopathy. Global Cardiology Science and Practice, 2019, 1-13. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Tang, L., Li, X., Zhou, N., Jiang, Y., Pan, C. and Shu, X. (2022) Echocardiographic Characteristics of PRKAG2 Syndrome: A Research Using Three-Dimensional Speckle Tracking Echocardiography Compared with Sarcomeric Hypertrophic Cardiomyopathy. Cardiovascular Ultrasound, 20, Article No. 14. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Drinko, J.K., Nash, P.J., Lever, H.M. and Asher, C.R. (2004) Safety of Stress Testing in Patients with Hypertrophic Cardiomyopathy. The American Journal of Cardiology, 93, 1443-1444. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
El Assaad, I., Gauvreau, K., Rizwan, R., Margossian, R., Colan, S. and Chen, M.H. (2020) Value of Exercise Stress Echocardiography in Children with Hypertrophic Cardiomyopathy. Journal of the American Society of Echocardiography, 33, 888-894.e2. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Elliott, P.M., Anastasakis, A., Borger, M.A., et al. (2014) 2014 ESC Guidelines on Diagnosis and Management of Hy-pertrophic Cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). European Heart Journal, 35, 2733-2779.
|
|
[32]
|
Suzuki, K. and Akashi, Y.J. (2017) Exercise Stress Echocardiography in Hypertrophic Cardiomyopathy. Journal of Echocardiography, 15, 110-117. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Nemes, A., Balázs, E., Soliman, O.I.I., Sepp, R., Csanády, M. and Forster, T. (2009) Long-Term Prognostic Value of Coronary Flow Velocity Reserve in Patients with Hypertrophic Cardiomyopathy: 9-Year Follow-Up Results from SZEGED Study. Heart and Vessels, 24, 352-356. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Afonso, L., Briasoulis, A., Mahajan, N., Kondur, A., Siddiqui, F., Siddiqui, S., et al. (2015) Comparison of Right Ventricular Contractile Abnormalities in Hypertrophic Cardiomyopathy versus Hypertensive Heart Disease Using Two Dimensional Strain Imaging: A Cross-Sectional Study. The International Journal of Cardiovascular Imaging, 31, 1503-1509. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Rowin, E.J., Maron, B.J., Olivotto, I. and Maron, M.S. (2017) Role of Exercise Testing in Hypertrophic Cardiomyopathy. JACC: Cardiovascular Imaging, 10, 1374-1386. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Hirasawa, K., Izumo, M., Mizukoshi, K., Nishikawa, H., Sato, Y., Watanabe, M., et al. (2021) Prognostic Significance of Right Ventricular Function during Exercise in Asymptomatic/Minimally Symptomatic Patients with Nonobstructive Hypertrophic Cardiomyopathy. Echocardiography, 38, 916-923. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
杨帆, 王静, 康楠, 等. 运动负荷超声心动图联合斑点追踪成像评估肥厚型心肌病患者右心功能的研究[J]. 临床心血管病杂志, 2022, 38(12): 934-940.
|